I consent to the use of cookies on this page for analyses, personalised content, advertising and web analysis services.

Vliwasorb® adhesive

The self-adhesive Superabsorbent Dressing

Fields of application

  • wounds with high levels of exudate
  • superficial wounds during the inflammatory phase, e.g. :
    • arterial and venous ulcers
    • burns and scalds (3rd degree: following surgical debridement)
  • postoperative wounds healing by secondary intention
  • laparotomy wounds
  • fistulas

Properties

  • high absorption and retention capacity for wound exudate
  • absorbent core with superabsorbent polymers that absorbs 20 times its own weight
  • saves time and money thanks to fewer dressing changes
  • protects from wound edge maceration and promotes wound healing 5) 6)
  • attractive to patients: 5) 6)
    • thin
    • flexible
    • cushioning
  • reduces the risk of the product adhering to the wound 7) 8) 9) 10) 2) 20)
  • impermeable to bacteria and water* PU membrane 7) 8) 9) 10) 2) 20)

*according to DIN EN 13726-3 5) 6)

Advice

  • works very well under compression bandages
  • as a secondary dressing for wounds with high amounts of exudate in combination with dressings for moist wound care

Downloads

Find our brochures as PDF files in our download section. Go to downloads

Topics

    Vliwasorb® adhesive combines all the proven benefits of the superabsorbent wound dressing Vliwasorb® with easy retention. Unlike the non-adhesive version, Vliwasorb® adhesive with its elastic, skin-friendly adhesive membrane 28) is designed for use whenever quick and easy application is required. Vliwasorb® adhesive adheres securely without the need for additional retention. The elastic membrane backing adjusts to the expansion of the superabsorbent wound dressing. This allows the absorption and retention of large amounts of exudate.

    Advantages

    • suitable for use on parts of the body that are particularly difficult to treat 28)
      • quick and easy handling 28)
      • no additional retention required
      • elastic, skin-friendly adhesive membrane
    • effective exudate management ensures better quality of life
      • high absorption capacity
      • absorption of exudate, slough and debris 15) 6) 7) 8) 9)
      • absorbs excessive exudate
    • high absorption and retention capacity
      • remoistens effectively
      • protects from wound edge maceration
      • reduces microbial load by retaining microbes in the wound dressing 20) 2) 3) 14)

    Product composition

    polyethylene, polypropylene, cellulose, sodium polyacrylate (superabsorbent polymer)
    polyurethane membrane with skin-friendly polyacrylate adhesive (free of colophony and colophony derivatives)

    Ordering information

    Vliwasorb® adhesive

    self-adhesive, sterile, individually sealed
    Dimensions (cm)REFShipping units (piece)
    12 x 123099110/260
    15 x 153099210/330
    15 x 253099310/110
     
    2

    Wiegand C, Abel M, Ruth P, Hipler P. Polyacylate-superabsorbers bind inflammatory proteases in vitro. Poster. (2009b) 19th Conference of the European Wound Management Association (EWMA), 20.-22. May 2009, Helsinki, Finland.

     
    3

    Wiegand C, Abel M, Ruth P, Hipler UC. Superabsorbent polymer-containing wound dressings have a beneficial effect on wound healing by reducing PMN elastase concentration and inhibiting microbial growth. J Mater Sci Mater Med. 2011 Nov;22(11):2583-90.

     
    5

    Tadej M. The use of Flivasorb in highly exuding wounds. Br J Nurs. 2009 Aug 13-Sep 9;18(15):S38, S40-S42.

     
    6

    Faucher N, Safar H, Baret M, Philippe A, Farid R. Superabsorbent dressings for copiously exuding wounds. Br J Nurs (2012) 21(12): 22—28
 (Faucher N, Safar A, Baret M, Philippe A, Farid R. Interest of the superabsorbent dressing in the management of highly exudative wounds. Poster. 21st Conference of the European Wound Management Association (EWMA) 25 –27. May 2011, Brussels, Belgium.

     
    7

    Verrall D, Coulborn A, Bree-Aslan C. Evaluating a super absorbent dressing (Flivasorb) in highly exuding wounds. Br J Nurs. 2010 Apr 8-21;19(7):449-53.

     
    8

    Wiser M., Barnoussi El, C van Wijk C. Management of copious exuding wounds with a super absorbent dressing before grafting. Poster.21st Conference of the European Wound Management Association (EWMA).25 –27. May 2011, Brussels, Belgium.

     
    9

    El Zayyat N, Leconte M. A super absorbent dressing in the management of a perineal wound after abdomino-perineal amputation. Poster.21st Conference of the European Wound Management Association (EWMA).25 –27. May 2011, Brussels, Belgium.

     
    10

    Paule A. The management of maceration in a Nursing Home environment. 
Poster. (2009). WoundsUK: WoundCare Conference, 9-11. November 2009 Harrogate, United Kingdom.

     
    11

    In vitro evaluation of the adhesion disposition of Vliwasorb. Interne Daten 06/2012.

     
    14

    Wiegand C, Abel M, Muldoon J, Ruth P, Hipler UC. SAP-containing dressings exhibit sustained antimicrobial effects over 7 days in vitro. J Wound Care. 2013 Mar;22(3):120, 122-4, 126-7.

     
    15

    Tadej M. The use of Flivasorb in highly exuding wounds. Br J Nurs. 2009 Aug 13-Sep 9;18(15):S38, S40-S42.

     
    20

    Wiegand C, Abel M, Ruth P, Hipler P. Antibacterial and antifungal effect of polyacrylate superabsorbers. Poster. (2009a). 19th Conference of the European Wound Management Association (EWMA), 20.-22. May 2009, Helsinki, Finland.

     
    28

    Die einfache Handhabung und optimierte Versorgung im Vergleich zur nicht-klebenden Variante konnte klinisch an Einzelfällen gezeigt werden. Gregory L, Hampton S, Jones J, Kattell D, Ousey K, Price B, Tickle J, Verrall D, Whitmore L. Exudate Management. Patient-centred wound care Journal of WoundCare (Suppl) March 2013: P1-20).

    This website contains information on products and medical practices which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Medical practices and regulations can be different from one country to another.